Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
640
-
Total 13F shares, excl. options
-
73.6M
-
Shares change
-
+905K
-
Total reported value, excl. options
-
$23B
-
Value change
-
+$181M
-
Put/Call ratio
-
1.24
-
Number of buys
-
294
-
Number of sells
-
-357
-
Price
-
$313.00
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q2 2019
812 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2019.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 640 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.6M shares
of 105M outstanding shares and own 70.09% of the company stock.
Largest 10 shareholders include Capital World Investors (8.1M shares), VANGUARD GROUP INC (6.08M shares), BlackRock Inc. (6.05M shares), HARRIS ASSOCIATES L P (3.91M shares), STATE STREET CORP (3.47M shares), LOOMIS SAYLES & CO L P (3.28M shares), FMR LLC (3.2M shares), WELLINGTON MANAGEMENT GROUP LLP (1.78M shares), POLEN CAPITAL MANAGEMENT LLC (1.59M shares), and ALLIANCEBERNSTEIN L.P. (1.53M shares).
This table shows the top 640 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.